Leah A. Vardy

Leah A. Vardy

Auto-generated profile, based on publicly available information

Leah A. Vardy

Skin Research Institute of Singapore, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Developmental Cell
Verified
Journal Article
Closed access
WTWael Tadros
Wael Tadros
AGAaron L. Goldman
Aaron L. Goldman
TBTomas Babak
Tomas Babak
FMFiona Menzies
Fiona Menzies
LVLeah Vardy
Leah Vardy
HLHoward D. Lipshitz
Howard D. Lipshitz

1 September 2013 in Genes & Development
Verified
Journal Article
Open access
PDF file
MBMarco Bezzi
Marco Bezzi
STShun Xie Teo
Shun Xie Teo
JMJulius Muller
Julius Muller
WMWei Chuen Mok
Wei Chuen Mok
SSSanjeeb Kumar Sahu
Sanjeeb Kumar Sahu
Ernesto GuccioneErnesto Guccione
Ernesto Guccione
The tight control of gene expression at the level of both transcription and post-transcriptional RNA processing is essential for mammalian development. We here investigate the role of protein arginine methyltransferase 5 (PRMT5), a putative splicing regulator and transcriptional cofactor, in mammalian development. We demonstrate that selective deletion of PRMT5 in neural stem/progenitor cells (NPCs) leads to postnatal death in mice. At the molecular level, the absence of PRMT5 results in reduced methylation of Sm proteins, aberrant constitutive splicing, and the alternative splicing of specific mRNAs with weak 5′ donor sites. Intriguingly, the products of these mRNAs are, among others, several proteins regulating cell cycle progression. We identify Mdm4 as one of these key mRNAs that senses the defects in the spliceosomal machinery and transduces the signal to activate the p53 response, providing a mechanistic explanation of the phenotype observed in vivo. Our data demonstrate that PRMT5 is a master regulator of splicing in mammals and uncover a new role for the Mdm4 pre-mRNA, which could be exploited for anti-cancer therapy.

25 February 2013 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ODOliver Dreesen
Oliver Dreesen
ACAlexandre Chojnowski
Alexandre Chojnowski
POPeh Fern Ong
Peh Fern Ong
TZTian Yun Zhao
Tian Yun Zhao
JCJohn E. Common
John E. Common
ACAlan Colman
Alan Colman
The nuclear lamina consists of A- and B-type lamins. Mutations in LMNA cause many human diseases, including progeria, a premature aging syndrome, whereas LMNB1 duplication causes adult-onset autosomal dominant leukodystrophy (ADLD). LMNB1 is reduced in cells from progeria patients, but the significance of this reduction is unclear. In this paper, we show that LMNB1 protein levels decline in senescent human dermal fibroblasts and keratinocytes, mediated by reduced transcription and inhibition of LMNB1 messenger ribonucleic acid (RNA) translation by miRNA-23a. This reduction is also observed in chronologically aged human skin tissue. To determine whether altered LMNB1 levels cause senescence, we either increased or reduced LMNB1. Both LMNB1 depletion and overexpression inhibited proliferation, but only LMNB1 overexpression induced senescence, which was prevented by telomerase expression or inactivation of p53. This phenotype was exacerbated by a simultaneous reduction of LMNA/C. Our results demonstrate that altering LMNB1 levels inhibits proliferation and are relevant to understanding the molecular pathology of ADLD.

1 November 2017 in Molecular Plant
Verified
Journal Article
Closed access
XCXuean Cui
Xuean Cui
Zhe LiangZhe Liang
Zhe Liang
LSLisha Shen
Lisha Shen
QZQian Zhang
Qian Zhang
SBShengjie Bao
Shengjie Bao
HYHao Yu
Hao Yu

18 April 2016 in RNA
Verified
Journal Article
Open access
PDF file
JCJoana Carlevaro-Fita
Joana Carlevaro-Fita
ARAnisa Rahim
Anisa Rahim
RGRoderic Guigó
Roderic Guigó
LVLeah A. Vardy
Leah A. Vardy
Rory JohnsonRory Johnson
Rory Johnson
Recent footprinting studies have made the surprising observation that long noncoding RNAs (lncRNAs) physically interact with ribosomes. However, these findings remain controversial, and the overall proportion of cytoplasmic lncRNAs involved is unknown. Here we make a global, absolute estimate of the cytoplasmic and ribosome-associated population of stringently filtered lncRNAs in a human cell line using polysome profiling coupled to spike-in normalized microarray analysis. Fifty-four percent of expressed lncRNAs are detected in the cytoplasm. The majority of these (70%) have >50% of their cytoplasmic copies associated with polysomal fractions. These interactions are lost upon disruption of ribosomes by puromycin. Polysomal lncRNAs are distinguished by a number of 5′ mRNA-like features, including capping and 5′UTR length. On the other hand, nonpolysomal “free cytoplasmic” lncRNAs have more conserved promoters and a wider range of expression across cell types. Exons of polysomal lncRNAs are depleted of endogenous retroviral insertions, suggesting a role for repetitive elements in lncRNA localization. Finally, we show that blocking of ribosomal elongation results in stabilization of many associated lncRNAs. Together these findings suggest that the ribosome is the default destination for the majority of cytoplasmic long noncoding RNAs and may play a role in their degradation.

26 July 2011 in Stem Cells
Verified
Journal Article
Open access
PDF file
SBStephanie Brown
Stephanie Brown
Adrian TeoAdrian Teo
Adrian Teo
SPSiim Pauklin
Siim Pauklin
NHNicholas RF Hannan
Nicholas RF Hannan
CCCandy H.-H. Cho
Candy H.-H. Cho
LVLudovic Vallier
Ludovic Vallier
Activin/Nodal signaling is necessary to maintain pluripotency of human embryonic stem cells (hESCs) and to induce their differentiation toward endoderm. However, the mechanisms by which Activin/Nodal signaling achieves these opposite functions remain unclear. To unravel these mechanisms, we examined the transcriptional network controlled in hESCs by Smad2 and Smad3, which represent the direct effectors of Activin/Nodal signaling. These analyses reveal that Smad2/3 participate in the control of the core transcriptional network characterizing pluripotency, which includes Oct-4, Nanog, FoxD3, Dppa4, Tert, Myc, and UTF1. In addition, similar experiments performed on endoderm cells confirm that a broad part of the transcriptional network directing differentiation is downstream of Smad2/3. Therefore, Activin/Nodal signaling appears to control divergent transcriptional networks in hESCs and in endoderm. Importantly, we observed an overlap between the transcriptional network downstream of Nanog and Smad2/3 in hESCs; whereas, functional studies showed that both factors cooperate to control the expression of pluripotency genes. Therefore, the effect of Activin/Nodal signaling on pluripotency and differentiation could be dictated by tissue specific Smad2/3 partners such as Nanog, explaining the mechanisms by which signaling pathways can orchestrate divergent cell fate decisions.